ArticleClinical sarcoma research2018

A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.

Matteo M Trucco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.